333 related articles for article (PubMed ID: 21159657)
1. Identification of PP2A complexes and pathways involved in cell transformation.
Sablina AA; Hector M; Colpaert N; Hahn WC
Cancer Res; 2010 Dec; 70(24):10474-84. PubMed ID: 21159657
[TBL] [Abstract][Full Text] [Related]
2. The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation.
Dzulko M; Pons M; Henke A; Schneider G; Krämer OH
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188453. PubMed ID: 33068647
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation.
Arnold HK; Sears RC
Mol Cell Biol; 2006 Apr; 26(7):2832-44. PubMed ID: 16537924
[TBL] [Abstract][Full Text] [Related]
4. Identification of specific PP2A complexes involved in human cell transformation.
Chen W; Possemato R; Campbell KT; Plattner CA; Pallas DC; Hahn WC
Cancer Cell; 2004 Feb; 5(2):127-36. PubMed ID: 14998489
[TBL] [Abstract][Full Text] [Related]
5. The role of PP2A A subunits in tumor suppression.
Sablina AA; Hahn WC
Cell Adh Migr; 2007; 1(3):140-1. PubMed ID: 19262135
[TBL] [Abstract][Full Text] [Related]
6. Liprin alpha1 interacts with PP2A B56gamma.
Arroyo JD; Lee GM; Hahn WC
Cell Cycle; 2008 Feb; 7(4):525-32. PubMed ID: 18235218
[TBL] [Abstract][Full Text] [Related]
7. Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma.
Allen-Petersen BL; Risom T; Feng Z; Wang Z; Jenny ZP; Thoma MC; Pelz KR; Morton JP; Sansom OJ; Lopez CD; Sheppard B; Christensen DJ; Ohlmeyer M; Narla G; Sears RC
Cancer Res; 2019 Jan; 79(1):209-219. PubMed ID: 30389701
[TBL] [Abstract][Full Text] [Related]
8. Circumventing cellular control of PP2A by methylation promotes transformation in an Akt-dependent manner.
Jackson JB; Pallas DC
Neoplasia; 2012 Jul; 14(7):585-99. PubMed ID: 22904676
[TBL] [Abstract][Full Text] [Related]
9. PP2A Inactivation Mediated by
Sents W; Meeusen B; Kalev P; Radaelli E; Sagaert X; Miermans E; Haesen D; Lambrecht C; Dewerchin M; Carmeliet P; Westermarck J; Sablina A; Janssens V
Cancer Res; 2017 Dec; 77(24):6825-6837. PubMed ID: 29046336
[TBL] [Abstract][Full Text] [Related]
10. Involvement of PP2A in viral and cellular transformation.
Arroyo JD; Hahn WC
Oncogene; 2005 Nov; 24(52):7746-55. PubMed ID: 16299534
[TBL] [Abstract][Full Text] [Related]
11. Functional importance of PP2A regulatory subunit loss in breast cancer.
Watt LF; Panicker N; Mannan A; Copeland B; Kahl RGS; Dun MD; Young B; Roselli S; Verrills NM
Breast Cancer Res Treat; 2017 Nov; 166(1):117-131. PubMed ID: 28744751
[TBL] [Abstract][Full Text] [Related]
12. Restricted protein phosphatase 2A targeting by Merkel cell polyomavirus small T antigen.
Kwun HJ; Shuda M; Camacho CJ; Gamper AM; Thant M; Chang Y; Moore PS
J Virol; 2015 Apr; 89(8):4191-200. PubMed ID: 25631078
[TBL] [Abstract][Full Text] [Related]
13. Protein phosphatase 2A PR130/B''alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling.
Zwaenepoel K; Goris J; Erneux C; Parker PJ; Janssens V
FASEB J; 2010 Feb; 24(2):538-47. PubMed ID: 19825976
[TBL] [Abstract][Full Text] [Related]
14. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
[TBL] [Abstract][Full Text] [Related]
15. Protein phosphatase 2A regulatory subunits and cancer.
Eichhorn PJ; Creyghton MP; Bernards R
Biochim Biophys Acta; 2009 Jan; 1795(1):1-15. PubMed ID: 18588945
[TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase 2A is regulated by protein kinase Cα (PKCα)-dependent phosphorylation of its targeting subunit B56α at Ser41.
Kirchhefer U; Heinick A; König S; Kristensen T; Müller FU; Seidl MD; Boknik P
J Biol Chem; 2014 Jan; 289(1):163-76. PubMed ID: 24225947
[TBL] [Abstract][Full Text] [Related]
17. CIP2A inhibits PP2A in human malignancies.
Junttila MR; Puustinen P; Niemelä M; Ahola R; Arnold H; Böttzauw T; Ala-aho R; Nielsen C; Ivaska J; Taya Y; Lu SL; Lin S; Chan EK; Wang XJ; Grènman R; Kast J; Kallunki T; Sears R; Kähäri VM; Westermarck J
Cell; 2007 Jul; 130(1):51-62. PubMed ID: 17632056
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated PP2A Aalpha subunits induce functional haploinsufficiency and tumorigenicity.
Chen W; Arroyo JD; Timmons JC; Possemato R; Hahn WC
Cancer Res; 2005 Sep; 65(18):8183-92. PubMed ID: 16166293
[TBL] [Abstract][Full Text] [Related]
19. Multiple pathways regulated by the tumor suppressor PP2A in transformation.
Westermarck J; Hahn WC
Trends Mol Med; 2008 Apr; 14(4):152-60. PubMed ID: 18329957
[TBL] [Abstract][Full Text] [Related]
20. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells.
Yeh E; Cunningham M; Arnold H; Chasse D; Monteith T; Ivaldi G; Hahn WC; Stukenberg PT; Shenolikar S; Uchida T; Counter CM; Nevins JR; Means AR; Sears R
Nat Cell Biol; 2004 Apr; 6(4):308-18. PubMed ID: 15048125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
